NICOLE GREENE: Open Payments
NPI 1538830989 · DRAPER, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 20 payments from 9 companies in 2025. Trend: 2023 $28 · 2024 $0 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Novo Nordisk Inc | 2 | $33 |
| Lundbeck LLC | 1 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Exact Sciences Corporation | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, Wegovy, REXULTI, JOURNAVX, VERQUVO, BREZTRI, Cologuard Collection Kit.
Industry payments across UT — which companies pay providers there.
